Open Access
Table I
Scoping review results − Gabapentinoids in the management of dental anxiety.
| Study | Study type | Methodological score | Number of patients | Indication | Gabapentinoid | Conclusion |
|---|---|---|---|---|---|---|
| Eskandarian et al. 2015 [11] | Double-blind crossover RCT | 62/100 | 21 | Anxiolytic premedication of children with dental anxiety | Single dose 75 mg pregabalin 2 h prior dental procedure | Rapid anxiolytic and sedative effect seen from 2 hour after oral administration No significant improvement in childrens' behavior ratings More effective behavior-guidance techniques in pregabalin group Higher number of “successful” treatment visits in pregabalin group |
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.